Mathematical Modeling of Folate Metabolism: Predicted Effects of Genetic Polymorphisms on Mechanisms and Biomarkers Relevant to Carcinogenesis
- 1 July 2008
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (7), 1822-1831
- https://doi.org/10.1158/1055-9965.epi-07-2937
Abstract
Low-folate status and genetic polymorphisms in folate metabolism have been linked to several cancers. Possible biological mechanisms for this association include effects on purine and thymidine synthesis, DNA methylation, or homocysteine concentrations. The influence of genetic variation in folate metabolism on these putative mechanisms or biomarkers of cancer risk has been largely unexplored. We used a mathematical model that simulates folate metabolism biochemistry to predict (a) the effects of polymorphisms with defined effects on enzyme function (MTHFR and TS) and (b) the effects of potential, as-of-yet-unidentified polymorphisms in a comprehensive set of folate-metabolizing enzymes on biomarkers and mechanisms related to cancer risk. The model suggests that there is substantial robustness in the pathway. Our predictions were consistent with measured effects of known polymorphisms in MTHFR and TS on biomarkers. Polymorphisms that alter enzyme function of FTD, FTS, and MTCH are expected to affect purine synthesis, FTS more so under a low-folate status. In addition, MTCH polymorphisms are predicted to influence thymidine synthesis. Polymorphisms in methyltransferases should affect both methylation rates and thymidylate synthesis. Combinations of polymorphisms in MTHFR, TS, and SHMT are expected to affect nucleotide synthesis in a nonlinear fashion. These investigations provide information on effects of genetic polymorphisms on biomarkers, including those that cannot be measured well, and highlight robustness and sensitivity in this complex biological system with regard to genetic variability. Although the proportional changes in biomarkers of risk with individual polymorphisms are frequently small, they may be quite relevant if present over an individual's lifetime. (Cancer Epidemiol Biomarkers Prev 2008;17(7):1822–31)Keywords
This publication has 57 references indexed in Scilit:
- Does Folic Acid Supplementation Prevent or Promote Colorectal Cancer? Results from Model-Based PredictionsCancer Epidemiology, Biomarkers & Prevention, 2008
- Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of dietCarcinogenesis: Integrative Cancer Research, 2007
- Folate restriction and methylenetetrahydrofolate reductase 677T polymorphism decreases adoMet synthesis via folate-dependent remethylation in human-transformed lymphoblastsLeukemia, 2007
- Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenomaGut, 2005
- A common insertion/deletion polymorphism of the thymidylate synthase (TYMS) gene is a determinant of red blood cell folate and homocysteine concentrationsHuman Genetics, 2005
- Physiology of Folate and Vitamin B12 in Health and DiseaseNutrition Reviews, 2004
- The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjectsHuman Genetics, 2004
- Relationship of Folate to Colorectal and Cervical Cancer: Review and Recommendations for PractitionersJournal of the American Dietetic Association, 2002
- Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levelsHuman Genetics, 2002
- Methylenetetrahydrofolate reductase C677T polymorphism does not alter folic acid deficiency-induced uracil incorporation into primary human lymphocyte DNA in vitroCarcinogenesis: Integrative Cancer Research, 2001